These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3293156)

  • 21. [Cytokine-based and targeted therapy of metastatic renal cell carcinoma--a current analysis].
    Johannsen M; Ringsdorf M; Römer A; Loening SA; Roigas J
    Aktuelle Urol; 2007 Jan; 38(1):38-45. PubMed ID: 17290328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of cytoreductive nephrectomy in the era of molecular targeted therapy.
    Polcari AJ; Gorbonos A; Milner JE; Flanigan RC
    Int J Urol; 2009 Mar; 16(3):227-33. PubMed ID: 19207114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy for advanced renal-cell carcinoma: 1983-1993.
    Yagoda A; Abi-Rached B; Petrylak D
    Semin Oncol; 1995 Feb; 22(1):42-60. PubMed ID: 7855619
    [No Abstract]   [Full Text] [Related]  

  • 24. [Second-line thalidomide/IL-2 therapy in metastatic kidney cancer--results of a pilot study].
    Schrader AJ; Heidenreich A; Hegele A; Olbert P; Varga Z; Hofmann R
    Aktuelle Urol; 2006 Nov; 37(6):429-35; quiz 423-4. PubMed ID: 17099831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-2 based immunotherapy in patients with metastatic renal cell carcinoma.
    Donskov F
    Dan Med Bull; 2007 Nov; 54(4):249-65. PubMed ID: 18208677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II cytotoxic chemotherapy trials in renal cell carcinoma: 1983-1988.
    Yagoda A
    Prog Clin Biol Res; 1990; 350():227-41. PubMed ID: 2201045
    [No Abstract]   [Full Text] [Related]  

  • 28. Optimizing treatment of metastatic renal cell carcinoma by changing mechanism of action.
    Larkin J; Swanton C; Pickering L
    Expert Rev Anticancer Ther; 2011 Apr; 11(4):639-49. PubMed ID: 21504330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is new in kidney cancer?
    Kirkali Z
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1753-5. PubMed ID: 19954286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in chemotherapy for renal cell carcinoma.
    Huben RP
    Semin Urol; 1992 Feb; 10(1):16-22. PubMed ID: 1565899
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal cell carcinoma therapy in 2010: many options with little comparative data.
    Pal SK; Figlin RA
    Clin Adv Hematol Oncol; 2010 Mar; 8(3):191-200. PubMed ID: 20400934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-based strategy for systemic treatment of metastatic renal cell carcinoma.
    Kirchner H; Strumberg D; Bahl A; Overkamp F
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):585-96. PubMed ID: 20397923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy of renal cell carcinoma: 1983-1989.
    Yagoda A
    Semin Urol; 1989 Nov; 7(4):199-206. PubMed ID: 2694257
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapeutic strategies for renal cell carcinoma.
    Milowsky MI; Nanus DM
    Urol Clin North Am; 2003 Aug; 30(3):601-9, x. PubMed ID: 12953758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging in metastatic renal cell carcinoma.
    Griffin N; Gore ME; Sohaib SA
    AJR Am J Roentgenol; 2007 Aug; 189(2):360-70. PubMed ID: 17646462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic chemotherapy and chemoimmunotherapy for metastatic renal cell cancer.
    Heinzer H; Huland E; Huland H
    World J Urol; 2001 Apr; 19(2):111-9. PubMed ID: 11374313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy in metastatic renal cell cancer.
    Lilleby W; Fosså SD
    World J Urol; 2005 Jul; 23(3):175-9. PubMed ID: 15726382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of metastatic renal cell carcinoma: review of experience and world literature.
    Luderer RC; Opipari MI; Perrotta AL
    J Am Osteopath Assoc; 1978 Apr; 77(8):590-603. PubMed ID: 649445
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of metastatic kidney cancer in elderly subjects].
    Escudier B; Paparel P; Neuzillet Y; Long JA; Rioux-Leclercq N; Correas JM; Lang H; Poissonnier L; Baumert H; Mejean A; Patard JJ
    Prog Urol; 2009 Nov; 19 Suppl 3():S129-32. PubMed ID: 20123496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new animal model for testing the effectiveness of chemotherapeutic agents on renal adenocarcinoma.
    White RD; Previte S; Olsson CA
    Surg Forum; 1978; 29():629-31. PubMed ID: 401284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.